Cargando…

Interleukin-13 receptor α2 DNA prime boost vaccine induces tumor immunity in murine tumor models

BACKGROUND: DNA vaccines represent an attractive approach for cancer treatment by inducing active T cell and B cell immune responses to tumor antigens. Previous studies have shown that interleukin-13 receptor α2 chain (IL-13Rα2), a tumor-associated antigen is a promising target for cancer immunother...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakashima, Hideyuki, Fujisawa, Toshio, Husain, Syed R, Puri, Raj K
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2993653/ https://www.ncbi.nlm.nih.gov/pubmed/21067607 http://dx.doi.org/10.1186/1479-5876-8-116

Ejemplares similares

Histone deacetylase inhibitiors enhance sensitivity of murine sarcoma tumors to IL-13-PE immunotoxin-based cancer therapy by upregulating IL-13Rα2 expression in vitro and in vivo
por: Fujisawa, Toshio, et al.
Publicado: (2013)

Targeting of interleukin-13 receptor α2 for treatment of head and neck squamous cell carcinoma induced by conditional deletion of TGF-β and PTEN signaling
por: Hall, Bradford, et al.
Publicado: (2013)

Histone modification enhances the effectiveness of IL-13 receptor targeted immunotoxin in murine models of human pancreatic cancer
por: Fujisawa, Toshio, et al.
Publicado: (2011)

Analysis of interleukin-13 receptor alpha2 expression as a prognostic biomarker in surgically resected pancreatic cancer patients
por: Fujisawa, Toshio, et al.
Publicado: (2015)

In Vivo Overexpression of IL-13 Receptor α2 Chain Inhibits Tumorigenicity of Human Breast and Pancreatic Tumors in Immunodeficient Mice
por: Kawakami, Koji, et al.
Publicado: (2001)

Interleukin 13 receptor alpha 2 directed immunotherapy targets hepatic fibrosis and tumorigenesis induced by choline deficient diet in an in vivo mouse model of nonalcoholic steatohepatitis
por: Fujisawa, Toshio, et al.
Publicado: (2014)

Modeling the effect of boost timing in murine irradiated sporozoite prime-boost vaccines
por: Fernandez-Arias, Cristina, et al.
Publicado: (2018)

Identification and characterization of cancer stem cells in human head and neck squamous cell carcinoma
por: Han, Jing, et al.
Publicado: (2014)

Generation of interleukin-13 receptor alpha2 antigen expressing modified vaccinia ankara recombinant virus for potential cancer immunotherapy
por: Sato, Yuki, et al.
Publicado: (2014)

Recent Advances in IL-13Rα2-Directed Cancer Immunotherapy
por: Knudson, Karin M., et al.
Publicado: (2022)

Intravenous heterologous prime-boost vaccination activates innate and adaptive immunity to promote tumor regression
por: Ramirez-Valdez, Ramiro A., et al.
Publicado: (2023)

P19-58 LB. Comparison of the immunogenicity in humans and rhesus macaques of vaccines consisting of DNA priming and MVA boosting and MVA priming and boosting
por: Robinson, HL, et al.
Publicado: (2009)

Immune Modulation Plus Tumor Ablation: Adjuvants and Antibodies to Prime and Boost Anti-Tumor Immunity In Situ
por: van den Bijgaart, Renske J. E., et al.
Publicado: (2021)

Breast cancer instructs dendritic cells to prime interleukin 13–secreting CD4(+) T cells that facilitate tumor development
por: Aspord, Caroline, et al.
Publicado: (2007)

The role of interleukin-13 in the removal of hyper-radiosensitivity by priming irradiation
por: Edin, Nina F. Jeppesen
Publicado: (2014)

IL-13Rα2 Is a Biomarker of Diagnosis and Therapeutic Response in Human Pancreatic Cancer
por: Fujisawa, Toshio, et al.
Publicado: (2021)

P-glycoprotein-targeted photodynamic therapy boosts cancer nanomedicine by priming tumor microenvironment
por: Mao, Chengqiong, et al.
Publicado: (2018)

Analysis of the cancer genome atlas (TCGA) database identifies an inverse relationship between interleukin-13 receptor α1 and α2 gene expression and poor prognosis and drug resistance in subjects with glioblastoma multiforme
por: Han, Jing, et al.
Publicado: (2017)

Heterologous prime boost COVID 19 vaccination
por: Launay, O., et al.
Publicado: (2022)

Identification of a novel role of IL-13Rα2 in human Glioblastoma multiforme: interleukin-13 mediates signal transduction through AP-1 pathway
por: Bhardwaj, Rukmini, et al.
Publicado: (2018)

Ebola-GP DNA Prime rAd5-GP Boost: Influence of Prime Frequency and Prime/Boost Time Interval on the Immune Response in Non-human Primates
por: Marcus, Hadar, et al.
Publicado: (2021)

HIVIS-DNA or HIVISopt-DNA priming followed by CMDR vaccinia-based boosts induce both humoral and cellular murine immune responses to HIV
por: Hinkula, J, et al.
Publicado: (2017)

Protection of Rhesus Monkeys by a DNA Prime/Poxvirus Boost Malaria Vaccine Depends on Optimal DNA Priming and Inclusion of Blood Stage Antigens
por: Weiss, Walter R., et al.
Publicado: (2007)

Heterologous prime-boost immunization co-targeting dual antigens inhibit tumor growth and relapse
por: Guo, Qianqian, et al.
Publicado: (2020)

Heterologous Prime-Boost Vaccination with Commercial FMD Vaccines Elicits a Broader Immune Response than Homologous Prime-Boost Vaccination in Pigs
por: Kim, Jaejo, et al.
Publicado: (2023)

Antitumor and antimetastatic activity of interleukin 12 against murine tumors
Publicado: (1993)

Interleukin-1α associates with the tumor suppressor p53 following DNA damage
por: Novak, J., et al.
Publicado: (2020)

Prime-boost using Separate Oncolytic Viruses in Combination with Checkpoint Blockade Improves Anti-tumor Therapy
por: Ilett, Elizabeth, et al.
Publicado: (2016)

A Novel Role of Interleukin 13 Receptor alpha2 in Perineural Invasion and its Association with Poor Prognosis of Patients with Pancreatic Ductal Adenocarcinoma †
por: Fujisawa, Toshio, et al.
Publicado: (2020)

Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy
por: McAuliffe, James, et al.
Publicado: (2021)

Prime-boost immunization by both DNA vaccine and oncolytic adenovirus expressing GM-CSF and shRNA of TGF-β2 induces anti-tumor immune activation
por: Kim, So Young, et al.
Publicado: (2017)

Heterologous Prime-Boost Vaccination Enhances TsPmy’s Protective Immunity against Trichinella spiralis Infection in a Murine Model
por: Wang, Lei, et al.
Publicado: (2017)

Mucosal prime-boost immunization with live murine pneumonia virus-vectored SARS-CoV-2 vaccine is protective in macaques
por: Buchholz, Ursula, et al.
Publicado: (2023)

Protection of chicken against very virulent IBDV provided by in ovo priming with DNA vaccine and boosting with killed vaccine and the adjuvant effects of plasmid-encoded chicken interleukin-2 and interferon-γ
por: Park, Jeong Ho, et al.
Publicado: (2009)

Priming with a DNA vaccine and boosting with an inactivated vaccine enhance the immune response against infectious bronchitis virus
por: Guo, Zicheng, et al.
Publicado: (2010)

Testing the Efficacy of a Multi-Component DNA-Prime/DNA-Boost Vaccine against Trypanosoma cruzi Infection in Dogs
por: Aparicio-Burgos, José E., et al.
Publicado: (2011)

Adjuvant-dependent cytokine profiles in the context of a DNA prime-protein boost HIV-1 vaccine
por: Buglione-Corbett, R, et al.
Publicado: (2012)

Orf virus DNA prime-protein boost strategy is superior to adenovirus-based vaccination in mice and sheep
por: Wang, Yan, et al.
Publicado: (2023)

Interleukin-13 peptide vaccine induces protective humoral immunity in murine asthma models
por: Wu, Fengbo, et al.
Publicado: (2017)

Langerhans Cell Migration in Murine Cutaneous Leishmaniasis: Regulation by Tumor Necrosis Factor α Interleukin-1β, and Macrophage Inflammatory Protein-1α
por: Arnoldi, Jörg, et al.
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_6359fpus6ejpp1rj02ovc91s0h